Catalyst Wire Dossier Catalyst Wire Dossier

Cell Therapy (Sen-xxx) - Sentien Biotechnologies

· Sentien Biotechnologies, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cell Therapy (Sen-xxx) - Sentien Biotechnologies, covering 2021-03-16 to 2021-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy [Phase 1, Phase 2]

See pricing